Study of PYX-106 in Solid Tumors
NCT05718557
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
47
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
PYX-106
Sponsor
Pyxis Oncology, Inc